Original article. Potential risk of dihydroergotamine causing medicationoveruse headache: preclinical evidence Cover

.blurhash-client-img { display: none !important; }

Original article. Potential risk of dihydroergotamine causing medicationoveruse headache: preclinical evidence

Asian Biomedicine

Volume 8 (2014): Issue 3 (June 2014)

By: Suteera Vibulyaseck, Saknan Bongsebandhu-phubhakdi, Supang Maneesri le Grand and Anan Srikiatkhachorn

Open Access

|Feb 2017

Authors

Suteera Vibulyaseck

Thailand

Saknan Bongsebandhu-phubhakdi

Thailand

Supang Maneesri le Grand

Thailand

Anan Srikiatkhachorn

Thailand

DOI: https://doi.org/10.5372/1905-7415.0802.296 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415

Journal RSS Feed

Language: English

Page range: 323 - 331

Published on: Feb 4, 2017

Published by: Chulalongkorn University

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

Cortical excitability,

cortical spreading depression,

c-Fos expression,

dihydroergotamine,

medication-overuse headache,

trigeminal nociception

Related subjects:

Assistive professions, nursing,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Clinical medicine, other

© 2017 Suteera Vibulyaseck, Saknan Bongsebandhu-phubhakdi, Supang Maneesri le Grand, Anan Srikiatkhachorn, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 8 (2014): Issue 3 (June 2014)Next article